JACC: Heart Failure publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart
failure patients. The goal of the Journal is to improve our understanding of the disease, clinical trial, clinical outcomes, and advances
in therapies through timely, insightful scientific communication. The Journal embraces interdisciplinary relationships with neuroscience,
pulmonary medicine, nephrology, electrophysiology, and surgery as they relate to heart failure. In addition, the Journal includes articles
concerning pharmacogenetics, biomarkers, and metabolomics.
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and handheld, we are able to supply the information you need in the most convenient format.